Registered protocol
INPLASY202690113
Protocol title
Disitamab Vedotin-Based Neoadjuvant or Bladder-Sparing Therapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
Keywords
- disitamab vedotin
- RC48
- muscle-invasive bladder cancer
- neoadjuvant therapy
- bladder preservation
Additional keywords may be available in the full-text protocol.
Registration timing
Prospective
Review stage at registration
The review has not yet started